Venrock Adviser, LLC Diversified Active

Location: New York, NY

CIK: 0001615982 · Show all filings

Period: Q2 2023 (← Previous) (Next →)

Filing Date: Aug 11, 2023

Total Value: $625M (100.0% shares, 0.0% debt)

Holdings (30)

VRDN VIRIDIAN THERAPEUTICS INC 11.7%

Value $73.34M Shares 3,082,622 Est. Cost $20.23 Unrealized +26.8%

COGT COGENT BIOSCIENCES INC 8.9%

Value $55.46M Shares 4,684,132 Est. Cost $8.79 Unrealized +30.6%

FDMT 4D MOLECULAR THERAPEUTICS IN 8.7%

Value $54.21M Shares 3,000,000 Est. Cost $18.41 Unrealized 0.0%

ELVN ENLIVEN THERAPEUTICS INC 7.3%

Value $45.52M Shares 2,230,127 Est. Cost $20.34 Unrealized -0.6%

— MERUS N V 7.3%

Value $45.45M Shares 1,726,214 Est. Cost $18.62 Unrealized —

GHRS GH RESEARCH PLC 6.7%

Value $41.73M Shares 3,517,125 Est. Cost $17.34 Unrealized -40.8%

— AMBRX BIOPHARMA INC 6.5%

Value $40.9M Shares 2,484,960 Est. Cost $8.92 Unrealized —

KALV KALVISTA PHARMACEUTICALS INC 4.2%

Value $26.25M Shares 2,916,667 Est. Cost $5.36 Unrealized +72.1%

TERN TERNS PHARMACEUTICALS INC 4.2%

Value $26.01M Shares 2,972,869 Est. Cost $3.72 Unrealized +213.7%

CABA CABALETTA BIO INC 4.1%

Value $25.47M Shares 1,973,251 Est. Cost $3.87 Unrealized +180.7%

DYN DYNE THERAPEUTICS INC 3.9%

Value $24.46M Shares 2,173,913 Est. Cost $11.80 Unrealized 0.0%

CELC CELCUITY INC 3.7%

Value $23.12M Shares 2,105,386 Est. Cost $10.24 Unrealized +1.5%

SVRA SAVARA INC 3.2%

Value $20.29M Shares 6,351,531 Est. Cost $1.32 Unrealized +78.3%

PHVS PHARVARIS N V 3.2%

Value $20.08M Shares 1,326,200 Est. Cost $9.62 Unrealized 0.0%

RYTM RHYTHM PHARMACEUTICALS INC 2.9%

Value $17.97M Shares 1,090,000 Est. Cost $18.05 Unrealized 0.0%

ORIC ORIC PHARMACEUTICALS INC 2.7%

Value $16.63M Shares 2,142,856 Est. Cost $5.68 Unrealized 0.0%

ACRS ACLARIS THERAPEUTICS INC 1.7%

Value $10.79M Shares 1,040,754 Est. Cost $13.57 Unrealized -33.3%

TRVI TREVI THERAPEUTICS INC 1.3%

Value $8.18M Shares 3,422,397 Est. Cost $2.46 Unrealized +2.3%

— APPLIED THERAPEUTICS INC 1.2%

Value $7.242M Shares 5,658,034 Est. Cost $1.28 Unrealized —

— THESEUS PHARMACEUTICALS INC 1.1%

Value $7.184M Shares 770,000 Est. Cost $8.88 Unrealized —

MIST MILESTONE PHARMACEUTICALS IN 1.0%

Value $6.295M Shares 2,208,812 Est. Cost $7.58 Unrealized -50.3%

— ADVERUM BIOTECHNOLOGIES INC 1.0%

Value $6.179M Shares 3,886,246 Est. Cost $1.59 Unrealized —

— PRAXIS PRECISION MEDICINES I 1.0%

Value $6.1M Shares 5,304,410 Est. Cost $1.15 Unrealized —

PLRX PLIANT THERAPEUTICS INC 0.8%

Value $5.236M Shares 288,949 Est. Cost $21.42 Unrealized +10.5%

— LYRA THERAPEUTICS INC 0.6%

Value $3.798M Shares 924,170 Est. Cost $5.65 Unrealized —

— AEGLEA BIOTHERAPEUTICS INC 0.5%

Value $2.858M Shares 6,343,221 Est. Cost $0.45 Unrealized —

BDTX BLACK DIAMOND THERAPEUTICS I 0.3%

Value $1.786M Shares 353,629 Est. Cost $2.04 Unrealized 0.0%

— RALLYBIO CORP 0.2%

Value $1.52M Shares 268,532 Est. Cost $7.55 Unrealized —

— AFFIMED N V 0.1%

Value $855K Shares 1,428,571 Est. Cost $5.52 Unrealized —

— AVALO THERAPEUTICS INC 0.1%

Value $444K Shares 1,250,000 Est. Cost $1.47 Unrealized —

Ticker	Issuer	Shares	Value	%	Est. Cost	Unrealized	Class	CUSIP
VRDN	VIRIDIAN THERAPEUTICS INC	3,082,622	$73.34M	11.7%	$20.23	+26.8%	COM	92790C104
COGT	COGENT BIOSCIENCES INC	4,684,132	$55.46M	8.9%	$8.79	+30.6%	COM	19240Q201
FDMT	4D MOLECULAR THERAPEUTICS IN	3,000,000	$54.21M	8.7%	$18.41	0.0%	COM	35104E100
ELVN	ENLIVEN THERAPEUTICS INC	2,230,127	$45.52M	7.3%	$20.34	-0.6%	COM	29337E102
—	MERUS N V	1,726,214	$45.45M	7.3%	$18.62	—	COM	N5749R100
GHRS	GH RESEARCH PLC	3,517,125	$41.73M	6.7%	$17.34	-40.8%	ORDINARY SHARES	G3855L106
—	AMBRX BIOPHARMA INC	2,484,960	$40.9M	6.5%	$8.92	—	SPONSORED ADS	02290A102
KALV	KALVISTA PHARMACEUTICALS INC	2,916,667	$26.25M	4.2%	$5.36	+72.1%	COM	483497103
TERN	TERNS PHARMACEUTICALS INC	2,972,869	$26.01M	4.2%	$3.72	+213.7%	COM	880881107
CABA	CABALETTA BIO INC	1,973,251	$25.47M	4.1%	$3.87	+180.7%	COM	12674W109
DYN	DYNE THERAPEUTICS INC	2,173,913	$24.46M	3.9%	$11.80	0.0%	COM	26818M108
CELC	CELCUITY INC	2,105,386	$23.12M	3.7%	$10.24	+1.5%	COM	15102K100
SVRA	SAVARA INC	6,351,531	$20.29M	3.2%	$1.32	+78.3%	COM	805111101
PHVS	PHARVARIS N V	1,326,200	$20.08M	3.2%	$9.62	0.0%	COM	N69605108
RYTM	RHYTHM PHARMACEUTICALS INC	1,090,000	$17.97M	2.9%	$18.05	0.0%	COM	76243J105
ORIC	ORIC PHARMACEUTICALS INC	2,142,856	$16.63M	2.7%	$5.68	0.0%	COM	68622P109
ACRS	ACLARIS THERAPEUTICS INC	1,040,754	$10.79M	1.7%	$13.57	-33.3%	COM	00461U105
TRVI	TREVI THERAPEUTICS INC	3,422,397	$8.18M	1.3%	$2.46	+2.3%	COM	89532M101
—	APPLIED THERAPEUTICS INC	5,658,034	$7.242M	1.2%	$1.28	—	COM	03828A101
—	THESEUS PHARMACEUTICALS INC	770,000	$7.184M	1.1%	$8.88	—	COM	88369M101
MIST	MILESTONE PHARMACEUTICALS IN	2,208,812	$6.295M	1.0%	$7.58	-50.3%	COM	59935V107
—	ADVERUM BIOTECHNOLOGIES INC	3,886,246	$6.179M	1.0%	$1.59	—	COM	00773U108
—	PRAXIS PRECISION MEDICINES I	5,304,410	$6.1M	1.0%	$1.15	—	COM	74006W108
PLRX	PLIANT THERAPEUTICS INC	288,949	$5.236M	0.8%	$21.42	+10.5%	COM	729139105
—	LYRA THERAPEUTICS INC	924,170	$3.798M	0.6%	$5.65	—	COM	55234L105
—	AEGLEA BIOTHERAPEUTICS INC	6,343,221	$2.858M	0.5%	$0.45	—	COM	00773J103
BDTX	BLACK DIAMOND THERAPEUTICS I	353,629	$1.786M	0.3%	$2.04	0.0%	COM	09203E105
—	RALLYBIO CORP	268,532	$1.52M	0.2%	$7.55	—	COM	75120L100
—	AFFIMED N V	1,428,571	$855K	0.1%	$5.52	—	COM	N01045108
—	AVALO THERAPEUTICS INC	1,250,000	$444K	0.1%	$1.47	—	COM NEW	05338F207